×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Reporting a Concern

Amgen has established various ways for individuals to raise matters of concern regarding the conduct of Company officials, or ethical, legal or other issues related to the way the Company is conducting its business. One avenue for raising such issues, the Business Conduct Hotline, is described below. Additional avenues are identified in our Code of Conduct.

Contacting the Business Conduct Hotline

Main Number: (888) 376-5574
Webform URL: https://amgenbch.tnwreports.com

The Business Conduct Hotline offers two options for making a report or asking a question, both managed by a third-party vendor and available globally 24 hours a day, every day. A concern can be reported or a question asked through the telephone line in any language by asking for a translator. The webform is available in multiple languages. Calls are not recorded, and IP addresses are not retained.

In most places, reports to the Business Conduct Hotline can be made anonymously (see further information on Anonymity and Confidentiality below). The reporter will be asked for details about the issue or question and given a unique reference number for follow up. Though not required, individuals are encouraged to leave a name and number in case additional information is needed.

Amgen takes all reports to the Business Conduct Hotline seriously and handles reports on a case-by-case basis. Investigations are handled in a manner that, in our view, is as confidential as possible under the circumstances. The company will determine whether misconduct has occurred and will take the action it decides is appropriate.

Reporters can contact the Business Conduct Hotline at any time during the process to request follow-up information or final feedback using the reference number originally given when the concern was reported. Please be aware that we may be limited in the information that can be shared.

Note that investigations may take some time. Do not assume that nothing is happening just because it takes a while to close a matter.

Anonymity and Confidentiality

While reports to the Business Conduct Hotline may be made anonymously (except in those few countries were anonymity is legally not allowed), some issues such as Privacy reports, requests for guidance, concerns about compensation/performance reviews, are more efficiently handled if contact information is provided. Without sufficient details, the Company may not be able to investigate the matter fully or take appropriate action.